Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease

• Main Authors: Garcia-Miralles, Marta, Ooi, Jolene, Bardile, Costanza Ferrari, Tan, Liang Juin, George, Maya, Drum, Chester L, Lin, Rachel Yanping, Hayden, Michael R, Pouladi, Mahmoud A
• Other Authors: DEAN'S OFFICE (MEDICINE)
• Format: Article
• Language: English
• Published: ACADEMIC PRESS INC ELSEVIER SCIENCE 2022
• Subjects: Science & Technology; Life Sciences & Biomedicine; Neurosciences; Neurosciences & Neurology; Huntington's disease; Monoamine oxidase; Monoamine oxidase inhibitors; Mouse model; Psychiatric features; Depression; Anxiety; Monoamines; HIPPOCAMPAL NEUROGENESIS; GENE CARRIERS; OXIDASE; DEPRESSION; DYSFUNCTION; BEHAVIOR; ANXIETY; LITHIUM; MICE; PATHOGENESIS
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/234700
• Institution: National University of Singapore

10.1016/j.expneurol.2016.01.019